2. Search Result
Search Result
Results for "

choleretic

" in MedChemExpress (MCE) Product Catalog:

17

Inhibitors & Agonists

1

Fluorescent Dye

1

Peptides

7

Natural
Products

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-106535
    Valbilan

    Febuprol

    		 Others Metabolic Disease
    Valbilan (Febuprol) is a choleretic agent. Valbilan exhibits spasmolytic and lipid lowering effects .
    Valbilan
  • HY-B1273
    Fenipentol

    1-Phenyl-1-pentanol

    		 Fluorescent Dye Endocrinology
    Fenipentol (1-Phenyl-1-pentanol), a synthetic derivative of an ingredient of Curcuma longa that is used as a condiment and dye. Fenipentol is also an orally active choleretic agent that plays an important role in release of secretin, gastrin, and pancreatic secretion of bicarbonate and protein .
    Fenipentol
  • HY-B1393
    Dehydrocholic acid

    		Drug Derivative Endocrinology
    Dehydrocholic acid is a product of the oxidation and synthesis of bile acids and the main component of the choleretic agent Decholin. Dehydrocholic acid can be used to increase bile production .
    Dehydrocholic acid
  • HY-17480
    Bendazac
    1 Publications Verification

    		 Others Inflammation/Immunology
    Bendazac is an oxyacetic acid with anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties. Bendazac acts by preventing protein denaturation and delays the cataractogenic process .
    Bendazac
  • HY-B1223
    Anethole trithione
    2 Publications Verification

    		 mAChR Neurological Disease Cancer
    Anethole trithione, a sulfur heterocyclic choleretic, is a bile secretion-stimulating agent. Anethole trithione enhances salivary secretion and increases mAChRs, and can be used for dry mouth research .
    Anethole trithione
  • HY-B1136
    Menbutone

    Genabilic acid

    		 Drug Derivative Metabolic Disease
    Menbutone (Genabilic acid), an oxobutyric acid derivative, is a choleretic. Menbutone can be used to treat digestive upsets (loss of appetite, indigestion, toxemia, or hepatic and pancreatic insufficiencies) in a variety of animal species, including different farm animals (cattle, sheep, goats, pigs), as well as in dogs .
    Menbutone
  • HY-B0998
    Dehydrocholate sodium

    Sodium dehydrocholate

    		 Amylases Lipase Autophagy Metabolic Disease
    Dehydrocholate sodium is an orally active hydrocholeretic agent. Dehydrocholate sodium modulates Autophagy, reduces serum amylase and lipase levels. Dehydrocholate sodium has the effects of promoting choleretic function, protecting the liver, reducing pancreatic damage, and regulating cholesterol metabolism. Dehydrocholate sodium can be used in the study of acute biliary pancreatitis and obstructive jaundice .
    Dehydrocholate sodium
  • HY-106537
    W 3699

    Probilin; Secrebil; Piprozolin

    		 Others Metabolic Disease
    W 3699 (Probilin; Secrebil; Piprozolin) is a choleretic agent that can be used in the study of biliary diseases .
    W 3699
  • HY-124491
    Moquizone

    		Others Neurological Disease Metabolic Disease
    Moquizone is a choleretic agent with arrhythmia-preventing activity .
    Moquizone
  • HY-118534
    Cyclobutyrol

    BRN-2209058

    		 Endogenous Metabolite Endocrinology
    Cyclobutyrol is a potent choleretic agent. Cyclobutyrol also inhibits biliary lipid secretion. Cyclobutyrol induces choleretic is unrelated to bile acids. Cyclobutyrol and bile acids do not compete for the hepatobiliar transport mechanisms[1]
    Cyclobutyrol
  • HY-118534A
    Cyclobutyrol sodium

    BRN-2209058 sodium

    		 Endogenous Metabolite Endocrinology
    Cyclobutyrol sodium is a potent choleretic agent. Cyclobutyrol sodium also inhibits biliary lipid secretion. Cyclobutyrol sodium induces choleretic is unrelated to bile acids. Cyclobutyrol sodium and bile acids do not compete for the hepatobiliar transport mechanisms[1]
    Cyclobutyrol sodium
  • HY-118311
    (Z)-W 3699

    (Z)-Probilin; (Z)-Secrebil; (Z)-Piprozolin

    		 Others Metabolic Disease
    (Z)-W 3699 is a potential choleretic. (Z)-W 3699 can increase the solubility of cholesterol in the gallbladder by altering the secretion of micellar bile acids. (Z)-W 3699 can prevent the formation of cholesterol-containing gallstones in dogs.
    (Z)-W 3699
  • HY-B1393R
    Dehydrocholic acid (Standard)

    		Drug Derivative Endocrinology
    Dehydrocholic acid (Standard) is the analytical standard of Dehydrocholic acid (HY-B1393). This product is intended for research and analytical applications. Dehydrocholic acid is a product of the oxidation and synthesis of bile acids and the main component of the choleretic agent Decholin. Dehydrocholic acid can be used to increase bile production.
    Dehydrocholic acid (Standard)
  • HY-Y0073
    4-Hydroxyacetophenone

    P-hydroxyacetophenone

    		 HBV Myosin Infection Inflammation/Immunology Cancer
    4-Hydroxyacetophenone (P-hydroxyacetophenone) is a major hepatoprotective and choleretic compound found in Artemisia and Illicium plants, exhibiting antiviral and anti-inflammatory effects against hepatitis B virus. Additionally, 4-Hydroxyacetophenone inhibits cancer cell adhesion, invasion, and migration by remodeling actin. 4-Hydroxyacetophenone holds promise for research in the fields of inflammatory diseases and cancer .
    4-Hydroxyacetophenone
  • HY-Y0073R
    4-Hydroxyacetophenone (Standard)

    		HBV Myosin Infection Inflammation/Immunology Cancer
    4-Hydroxyacetophenone (Standard) is the analytical standard of 4-Hydroxyacetophenone. This product is intended for research and analytical applications. 4-Hydroxyacetophenone (P-hydroxyacetophenone) is a major hepatoprotective and choleretic compound found in Artemisia and Illicium plants, exhibiting antiviral and anti-inflammatory effects against hepatitis B virus. Additionally, 4-Hydroxyacetophenone inhibits cancer cell adhesion, invasion, and migration by remodeling actin. 4-Hydroxyacetophenone holds promise for research in the fields of inflammatory diseases and cancer .
    4-Hydroxyacetophenone (Standard)
  • HY-N10319
    Artepillin C

    		Epigenetic Reader Domain Necroptosis TRP Channel Metabolic Disease Inflammation/Immunology Cancer
    Artepillin C is an orally active CREB/CRTC2 inhibitor and TRPA1 covalent agonist (EC50=1.8 μM). Artepillin C inhibits CREB/CRTC2-mediated gene transcription and downregulates BMAL1 expression to regulate glucose and lipid metabolism. Artepillin C can also activate TRPA1 channels to induce spicy taste signals. Artepillin C can inhibit tumor cell proliferation, induce necroptosis, improve insulin resistance and inhibit liver lipid synthesis. Artepillin C can be used in the study of metabolic syndrome, tumor prevention and treatment, and inflammation .
    Artepillin C
  • HY-N10319R
    Artepillin C (Standard)

    		Reference Standards TRP Channel Necroptosis Epigenetic Reader Domain Metabolic Disease Inflammation/Immunology Cancer
    Artepillin C (Standard) is the analytical standard of Artepillin C (HY-N10319). This product is intended for research and analytical applications. Artepillin C is an orally active CREB/CRTC2 inhibitor and TRPA1 covalent agonist (EC50=1.8 μM). Artepillin C inhibits CREB/CRTC2-mediated gene transcription and downregulates BMAL1 expression to regulate glucose and lipid metabolism. Artepillin C can also activate TRPA1 channels to induce spicy taste signals. Artepillin C can inhibit tumor cell proliferation, induce apoptosis, improve insulin resistance and inhibit liver lipid synthesis. Artepillin C can be used in the study of metabolic syndrome, tumor prevention and treatment, and inflammation .
    Artepillin C (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: